Dr. Erik Bogsch is Head of R&D and Manufacturing in the Biotechnology Business Unit of Gedeon Richter Plc, representing PregLem SA, a member of the Gedeon Richter group on the EBE Board. He is responsible for leading the R&D effort in the development of GR’s biotechnology pipeline.
Gedeon Richter Plc. is engaged in the development and manufacture of both bacterial cell fermentation based and mammalian cell fermentation based biosimilar products. GR has R&D, analytical & manufacturing capabilities in multiple locations in Hungary & Germany.
Dr. Bogsch, has a Natural Sciences degree from the University of Cambridge and a PhD in cell biology from the University of Warwick. Following a brief postdoctoral academic research career, he worked in the food industry for many years in R&D, Quality & Manufacturing roles in the UK, Hungary & Germany. He joined Gedeon Richter Plc. in 2012, as commissioning lead for GR’s biotechnology factory in Debrecen, Hungary, before moving into his current role in 2014.